Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, November 27, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Roche Test Identify Syphilis in Routine Samples and Donated Blood
Wednesday, March 12, 2014
Diagnostics division strengthens its position in the serology market and expands its immunoassay portfolio in infectious disease.

Dako Further Expands World's Leading Special Stain Solution for Cancer Diagnostics
Tuesday, March 04, 2014
Addition of New Jenner-Wright Giemsa stain to Company’s Dako Artisan™ Link portfolio.

Unilabs and Diagnoplex SA Announce the Swiss Market Launch of Colox
Saturday, March 01, 2014
A non-invasive colon cancer screening test.

New TouchTools™ PCR Wizard from Tecan
Wednesday, February 26, 2014
New tool aids automated PCR set-up and reduce training time and costs.

Do you Want to Make the Move from Diagnostics to BiognostiX?
Thursday, February 20, 2014
Symposium ‘Leading the way from diagnostics to BiognostiX’ to be held on 27 February 2014 in UK.

DiaSorin Marks Significant Growth in Molecular Extraction Kit Sales
Friday, February 14, 2014
Italian Voden Medical Instruments S.p.A. awarded DiaSorin Platinum Distributor status.

Greiner Bio-One Presents Innovative Cryo.s Biobanking Tubes
Friday, February 14, 2014
An innovative solution for storing biological samples in biorepositories.

GenomOncology To Enable CompanionDxTM Clinical Cancer Panels
Monday, February 10, 2014
The GO Clinical WorkbenchTM is selected to launch a series of next generation sequencing (NGS)-based assays.

EKF Molecular to Showcase PointMan™ DNA-enrichment Kits
Monday, February 10, 2014
EKF Diagnostics’ subsidiary company is exhibiting its ground-breaking technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 483
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv